Voyager Therapeutics (VYGR) Short Interest Ratio & Short Volume → Biggest hedge fund manager has huge warning for U.S. dollar (From Stansberry Research) (Ad) Free VYGR Stock Alerts $8.47 +0.03 (+0.36%) (As of 02:15 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Voyager Therapeutics Short Interest DataCurrent Short Volume4,210,000 sharesPrevious Short Volume3,460,000 sharesChange Vs. Previous Month+21.68%Dollar Volume Sold Short$32.92 millionShort Interest Ratio / Days to Cover6.4Last Record DateApril 30, 2024Outstanding Shares54,388,000 sharesPercentage of Shares Shorted7.74%Today's Trading Volume227,044 sharesAverage Trading Volume850,112 sharesToday's Volume Vs. Average27% Short Selling Voyager Therapeutics ? Sign up to receive the latest short interest report for Voyager Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVYGR Short Interest Over TimeVYGR Days to Cover Over TimeVYGR Percentage of Float Shorted Over Time Ad Stansberry ResearchBiggest hedge fund manager has huge warning for U.S. dollarPrescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."Get the details before it's taken offline. Voyager Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,210,000 shares $32.92 million +21.7%N/A6.4 $7.82 4/15/20243,460,000 shares $28.51 million +3.9%N/A5.5 $8.24 3/31/20243,330,000 shares $31.00 million +44.2%N/A4.4 $9.31 3/15/20242,310,000 shares $21.44 million +2.2%N/A2.5 $9.28 2/29/20242,260,000 shares $18.80 million +5.1%N/A2.9 $8.32 2/15/20242,150,000 shares $16.53 million +9.1%5.9%3.1 $7.69 Get the Latest News and Ratings for VYGR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Voyager Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,970,000 shares $14.32 million +8.8%5.4%3 $7.27 1/15/20241,810,000 shares $14.23 million +4.0%5.0%2.9 $7.86 12/31/20231,740,000 shares $14.69 million +1.8%N/A3.1 $8.44 12/15/20231,710,000 shares $13.65 million +3.0%4.9%8.5 $7.98 11/30/20231,660,000 shares $12.05 million -13.5%4.8%7.4 $7.26 11/15/20231,920,000 shares $12.92 million -4.5%5.5%8.3 $6.73 10/31/20232,010,000 shares $13.21 million -1.0%5.8%8.3 $6.57 10/15/20232,030,000 shares $15.00 million +1.0%5.9%7.7 $7.39 9/30/20232,010,000 shares $15.58 million +0.5%5.8%6.8 $7.75 9/15/20232,000,000 shares $15.92 million -3.9%5.7%6.1 $7.96 8/31/20232,080,000 shares $20.84 million +2.5%6.0%4.6 $10.02 8/15/20232,030,000 shares $19.29 million +4.1%5.8%3.8 $9.50 7/31/20231,950,000 shares $18.17 million -4.9%5.6%3 $9.32 7/15/20232,050,000 shares $19.50 million -2.4%6.0%3.1 $9.51 6/30/20232,100,000 shares $24.05 million +57.9%6.1%3.3 $11.45 6/15/20231,330,000 shares $17.52 million +10.8%3.9%2.2 $13.17 5/31/20231,200,000 shares $13.67 million +9.1%3.5%2.5 $11.39 5/15/20231,100,000 shares $11.44 million +7.8%3.2%2.5 $10.40 4/30/20231,020,000 shares $7.40 million No Change3.5%3 $7.25 4/15/20231,020,000 shares $8.23 million No Change3.5%3.5 $8.07 3/31/20231,020,000 shares $7.86 million No Change3.7%2.5 $7.71 3/15/20231,020,000 shares $8.18 million +23.0%3.7%2.6 $8.02 2/28/2023829,200 shares $5.95 million -1.7%3.3%2.3 $7.18 2/15/2023843,900 shares $6.40 million -1.9%3.4%2.7 $7.58 1/31/2023860,400 shares $8.12 million -21.8%3.1%2.9 $9.44 1/15/20231,100,000 shares $11.86 million +11.8%4.0%4.2 $10.78 12/30/2022983,600 shares $6.00 million +13.0%3.6%4.6 $6.10 12/15/2022870,200 shares $5.05 million +0.6%3.2%7 $5.80 11/30/2022865,100 shares $5.14 million -4.2%3.2%6.8 $5.94 11/15/2022902,700 shares $4.99 million -2.5%3.3%5.8 $5.53 10/31/2022926,200 shares $4.80 million +31.9%3.4%5 $5.18 10/15/2022702,300 shares $4.03 million -29.3%2.6%3.6 $5.74 9/30/2022993,400 shares $5.88 million -19.2%3.6%5 $5.92 9/15/20221,230,000 shares $8.25 million +12.8%4.5%5.9 $6.71Biggest hedge fund manager has huge warning for U.S. dollar (Ad)Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."Get the details before it's taken offline. VYGR Short Interest - Frequently Asked Questions What is Voyager Therapeutics' current short interest? Short interest is the volume of Voyager Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,210,000 shares of VYGR short. Learn More on Voyager Therapeutics' current short interest. What is a good short interest ratio for Voyager Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VYGR shares currently have a short interest ratio of 6.0. Learn More on Voyager Therapeutics's short interest ratio. Is Voyager Therapeutics' short interest increasing or decreasing? Voyager Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,210,000 shares, an increase of 21.7% from the previous total of 3,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Voyager Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Voyager Therapeutics: C4 Therapeutics, Inc. (14.74%), Editas Medicine, Inc. (24.93%), Taysha Gene Therapies, Inc. (9.04%), Adaptive Biotechnologies Co. (8.17%), Allogene Therapeutics, Inc. (32.03%), Alector, Inc. (10.20%), iTeos Therapeutics, Inc. (7.23%), Lexeo Therapeutics, Inc. (4.34%), Fate Therapeutics, Inc. (19.45%), ProKidney Corp. (22.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Voyager Therapeutics stock? Short selling VYGR is an investing strategy that aims to generate trading profit from Voyager Therapeutics as its price is falling. VYGR shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Voyager Therapeutics? A short squeeze for Voyager Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VYGR, which in turn drives the price of the stock up even further. How often is Voyager Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYGR, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: CCCC Short Squeeze EDIT Short Squeeze TSHA Short Squeeze ADPT Short Squeeze ALLO Short Squeeze ALEC Short Squeeze ITOS Short Squeeze LXEO Short Squeeze FATE Short Squeeze PROK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VYGR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity